Rheinfelden, Germany

Jörg Eder

USPTO Granted Patents = 2 


Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2009-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: The Innovative Contributions of Jörg Eder in the Field of Medicine

Introduction: Jörg Eder is a notable inventor based in Rheinfelden, Germany, recognized for his significant contributions in the medical field. With a total of two patents to his name, his work focuses on providing innovative solutions for renal diseases and disorders. Eder's inventions illustrate his dedication to advancing medical therapies, particularly in immunosuppressive and anti-inflammatory treatments.

Latest Patents: Eder's most recent patents include the following groundbreaking inventions:

1. **Uses of Piperidinyl-Indole Derivatives**: This invention pertains to the novel application of specific piperidinyl-indole derivatives in treating patients suffering from renal diseases, especially C3 glomerulopathy (C3G) and IgA nephropathy (IgAN). This development aims to improve patient outcomes and provide new therapeutic options for these challenging conditions.

2. **2-Aminopyrimidine Derivatives and Their Medical Use**: Eder's second patent features a compound of formula I, which can be utilized as a pharmaceutical or its acceptable salts, esters, or prodrugs. The patent describes methods for inhibiting IKK activity and TNF production, illustrating potential applications as immunosuppressants or anti-inflammatory agents, thereby enhancing the treatment landscape for various medical conditions.

Career Highlights: Currently, Jörg Eder is associated with Novartis AG, a global healthcare company renowned for its innovative medicines. His tenure at Novartis has allowed him to contribute to cutting-edge research and development in pharmacology, further solidifying his reputation as a leading inventor in the industry.

Collaborations: Throughout his career, Eder has worked alongside talented colleagues, including Birgit Bollbuck and Alastair Denholm. These collaborations have fostered a dynamic environment for innovation and have undoubtedly influenced the success of his patents.

Conclusion: Jörg Eder's contributions to medical science through his patents demonstrate his dedication to improving healthcare. His work with piperidinyl-indole and 2-aminopyrimidine derivatives presents promising avenues for treating renal disorders and highlights the essential role inventors play in the evolution of medical therapies. With continued partnerships and research, Eder's future endeavors will likely lead to even more groundbreaking innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…